Female-Founded Finnish Startup Audicin Raises €1.6 Million to Develop Audio Treatments for Nervous System Overstimulation

In a world where overstimulation is a constant companion, Audicin, a pioneering Finnish NeuroTech startup, is making waves with its innovative approach to nervous system regulation. Recently, Audicin announced a successful funding round, securing €1.6 million ($1.9 million) to further its mission. With a focus on brainwave entrainment and music neuroscience, the company is poised to transform how we manage stress, focus, and sleep.

Engaging Introduction

Founded in 2022 by Laura Avonius and Dr. Victoria Williamson, Audicin is leveraging cutting-edge neurotechnology to create real-time audio treatments. The startup's recent funding round attracted private investors, including notable figures like Petteri Lahtela, co-founder of Oura Ring, and Virpi Tuomivaara. Additionally, Business Finland’s Deep Tech Accelerator provided support, bringing Audicin’s total funding to approximately €2.5 million ($3 million).

Audicin's technology is designed to seamlessly integrate into everyday life, offering support without demanding user effort. "The nervous system doesn’t switch on only when something goes wrong," says CEO Laura Avonius. "Audicin helps regulate cognitive load in real-time, operating quietly in the background."

The company’s approach combines composed music tracks with binaural beats embedded in 360-degree spatial sound. These tracks, crafted by neuroscientists, medical doctors, and audio engineers, guide the brain into states of calm, focus, or recovery. Users can access these benefits through any headphones or earbuds, and the technology pairs effortlessly with wearables like Oura, Apple Watch, Garmin, and Whoop.

Audicin is also making strides in secure, phone-free environments. A pilot for a standalone, offline Sleep Headband is underway, featuring a pre-installed eight-hour recovery program based on a 1Hz delta protocol, which is associated with deep sleep.

Insights / Analysis

For startups, Audicin's approach represents a shift towards integrating wellness into the fabric of daily life. Unlike tools that require dedicated time for use, Audicin functions like infrastructure—operating during work, rest, and in restricted environments. This presents significant opportunities for enterprise deployment and third-party integration through its SDK, Audicin for Apps.

Petteri Lahtela emphasizes the company's potential, highlighting its non-reliance on ideal conditions. This adaptability positions Audicin to tap into diverse sectors, including defense, athletics, and wellness clinics. With a robust €6.9 million ($8 million) sales pipeline, the company is poised for substantial growth.

Conclusion

Audicin's innovative solutions are not just about technology; they're about redefining how we interact with our nervous systems. With strong commercial progress and a growing user base, the startup is setting a new standard in neurotechnology. As it continues to expand, Audicin offers a compelling model for how startups can integrate seamlessly into existing ecosystems, providing real-time support where it's needed most.

Source: EU-Startups